Bacimycin 500 IE/5mg, salve
Bacimycin 500 IE/5mg, salve
Not authorised
- CHLORHEXIDINE ACETATE
- BACITRACIN ZINC
Product identification
Medicine name:
Bacimycin 500 IE/5mg, salve
Active substance:
- CHLORHEXIDINE ACETATE
- BACITRACIN ZINC
Target species:
-
Dog
-
Cat
-
Cattle
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
CHLORHEXIDINE ACETATE5.00milligram(s)1.00gram(s)
-
BACITRACIN ZINC500.00international unit(s)1.00gram(s)
Pharmaceutical form:
-
Ointment
Withdrawal period by route of administration:
-
Cutaneous use
-
Dog
-
Cat
-
Cattle
-
Milkno withdrawal periodNot approved for cattle delivering milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD06AX05
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Expired
Authorised in:
-
Norway
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Actavis Group PTC ehf.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alpharma AS
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 2813
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 2/03/2023
bacimycin.pdf
Norwegian (PDF)
Download Published on: 21/04/2022
How useful was this page?: